Comparing clinical features of young onset, middle onset and late onset Parkinson's disease

被引:128
作者
Mehanna, Raja [1 ]
Moore, Suzanne [2 ]
Hou, J. Gabriel [2 ]
Sarwar, Aliya I. [2 ]
Lai, Eugene C. [3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Houston, TX USA
[3] Houston Methodist Neurol Inst, Houston, TX USA
关键词
Parkinson; Age at onset; Young onset; GENDER-DIFFERENCES; MOTOR FLUCTUATIONS; AGE; POPULATION; DYSKINESIA; SYMPTOMS; RISK; LIFE;
D O I
10.1016/j.parkreldis.2014.02.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Parkinson's disease (PD) affects 1-2% of the population over 65 years. There is evidence that the clinical features differ with age at symptom onset, but published information is scarce. Methods: We reviewed the charts of 593 PD patients and divided them into young onset (<= 49 years), middle onset (50-69 years) and late onset (>= 70 years) groups. Data collected included age at symptom onset, year of onset, family history of Parkinson's disease in first and second degree relatives, predominant first symptom, first anti parkinsonian medication prescribed, frequency of levodopa-induced dyskinesia, therapy related dystonia, therapy related gastrointestinal side effects, hallucination, dementia, depression and apathy. Results: The middle onset was the largest group (51%), followed by the late onset (39%) and the young onset (10%) groups. Young onset patients had a more frequent family history of Parkinson's disease and a longer survival. Symptoms other than tremor were more frequent as the initial symptom of the young onset group, and the frequency of tremor as the first symptom increased with advancing age at onset. Depression was more frequent in the young onset group. The frequency of treatment related dyskinesia or dystonia decreased with advancing age at onset. Conclusion: We have identified specific clinical differences in Parkinson's disease related to the patient's age at onset and added to the existing knowledge of the variability of disease presentation. We suggest an age of onset of 49 years or less for the definition of young onset PD. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:530 / 534
页数:5
相关论文
共 37 条
[1]   Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].
Ahlskog, JE ;
Muenter, MD .
MOVEMENT DISORDERS, 2001, 16 (03) :448-458
[2]   Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study [J].
Alves, G. ;
Mueller, B. ;
Herlofson, K. ;
HogenEsch, I. ;
Telstad, W. ;
Aarsland, D. ;
Tysnes, O-B ;
Larsen, J. P. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (08) :851-857
[3]   Clinical and pharmacological differences in early- versus late-onset Parkinson's disease [J].
Arevalo, GG ;
Jorge, R ;
Garcia, S ;
Scipioni, O ;
Gershanik, O .
MOVEMENT DISORDERS, 1997, 12 (03) :277-284
[4]  
Arias E, 2006, NATL VITAL STAT REPO, V2010, P58
[5]  
Bower JH, 2000, MOVEMENT DISORD, V15, P819, DOI 10.1002/1531-8257(200009)15:5<819::AID-MDS1009>3.0.CO
[6]  
2-P
[7]   What predicts mortality in Parkinson disease? A prospective population-based long-term study [J].
Forsaa, E. B. ;
Larsen, J. P. ;
Wentzel-Larsen, T. ;
Alves, G. .
NEUROLOGY, 2010, 75 (14) :1270-1276
[8]  
FRIEDMAN A, 1994, ACTA NEUROL SCAND, V89, P258
[9]   What Factors Influence Motor Complications in Parkinson Disease?: A 10-Year Prospective Study [J].
Garcia-Ruiz, Pedro J. ;
del Val, Javier ;
Mahillo Fernandez, Ignacio ;
Herranz, Antonio .
CLINICAL NEUROPHARMACOLOGY, 2012, 35 (01) :1-5
[10]  
GERSHANIK OS, 1990, ADV NEUROL, V53, P251